| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y605-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-0203 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0657f3e344a9f1acad722a5647b598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3672b868ee94293603ec2bb1869ee049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbc3028cc40722b3637541b2cf6a6c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d87eb36874608fa79ecef2752a86a7a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a935e11b801cab10085a03d21cf8b4a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e59dcc2584397e7ae71f7b0ea9e61b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc6eba190e55e6cefcc972b5e0bb7fcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115e7711a34a41c6ce8c1be10d19b78c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f15255af66b4fc103e772b84640be661 |
| publicationDate |
2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3321377-A1 |
| titleOfInvention |
Method for determining sensitivity to simultaneous inhibitor against parp and tankyrase |
| abstract |
The present invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. According to the present invention, a colorectal treatment effect can be maximized by sorting patients having sensitivity to the simultaneous inhibitor against PARP and Tankyrase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018521033-A |
| priorityDate |
2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |